mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.009 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.009 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.009 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.01 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |